ES517865A0 - Un procedimiento para la preparacion de pirimidin-2-onas-sustituidas. - Google Patents

Un procedimiento para la preparacion de pirimidin-2-onas-sustituidas.

Info

Publication number
ES517865A0
ES517865A0 ES517865A ES517865A ES517865A0 ES 517865 A0 ES517865 A0 ES 517865A0 ES 517865 A ES517865 A ES 517865A ES 517865 A ES517865 A ES 517865A ES 517865 A0 ES517865 A0 ES 517865A0
Authority
ES
Spain
Prior art keywords
sup
sub
group
ring
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES517865A
Other languages
English (en)
Other versions
ES8405771A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nyegaard and Co AS
Original Assignee
Nyegaard and Co AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nyegaard and Co AS filed Critical Nyegaard and Co AS
Publication of ES517865A0 publication Critical patent/ES517865A0/es
Publication of ES8405771A1 publication Critical patent/ES8405771A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/38One sulfur atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
ES517865A 1981-01-09 1982-12-01 Un procedimiento para la preparacion de pirimidin-2-onas-sustituidas. Expired ES8405771A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8100613 1981-01-09

Publications (2)

Publication Number Publication Date
ES517865A0 true ES517865A0 (es) 1984-06-16
ES8405771A1 ES8405771A1 (es) 1984-06-16

Family

ID=10518891

Family Applications (2)

Application Number Title Priority Date Filing Date
ES508593A Expired ES8304945A1 (es) 1981-01-09 1982-01-08 "un procedimiento para la preparacion de pirimidin-2-onas sustituidas".
ES517865A Expired ES8405771A1 (es) 1981-01-09 1982-12-01 Un procedimiento para la preparacion de pirimidin-2-onas-sustituidas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES508593A Expired ES8304945A1 (es) 1981-01-09 1982-01-08 "un procedimiento para la preparacion de pirimidin-2-onas sustituidas".

Country Status (12)

Country Link
US (2) US4596870A (es)
EP (1) EP0056319B1 (es)
JP (1) JPS57136575A (es)
AT (1) ATE19242T1 (es)
AU (1) AU7929482A (es)
CA (1) CA1180710A (es)
DE (1) DE3270525D1 (es)
DK (1) DK5382A (es)
ES (2) ES8304945A1 (es)
NO (1) NO160514C (es)
NZ (1) NZ199447A (es)
ZA (1) ZA82125B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK83783A (da) * 1982-02-24 1983-08-25 Nyegaard & Co As Fremgangsmaade til fremstilling af substituerede pyrimidin-2-oner
GB2135992B (en) * 1983-01-11 1986-09-24 Nyegaard & Co As Substituted pyrimidines and processes for their preparation
EP0119457B1 (de) * 1983-02-23 1986-12-30 Bayer Ag Mittel zur Regulierung des Pflanzenwachstums
GB8411291D0 (en) * 1984-05-02 1984-06-06 Nyegaard & Co As Chemical compounds
US4864021A (en) * 1984-10-30 1989-09-05 Otsuka Pharmaceutical Co., Ltd. 5-fluorouracil derivatives
US4675321A (en) * 1986-02-07 1987-06-23 Merck & Co., Inc. Substituted pyrimidines useful as calcium channel blockers
US4849426A (en) * 1987-05-15 1989-07-18 Pearlman Dale L Method for treating actinic keratosis with cytotoxic agents
US4820711A (en) * 1987-05-15 1989-04-11 Pearlman Dale L Method for treating actinic keratosis with cytotoxic agents
US4853388A (en) * 1987-05-15 1989-08-01 Pearlman Dale L Method for treating psoriasis with cytotoxic agents
US8933239B1 (en) * 2013-07-16 2015-01-13 Dow Global Technologies Llc Bis(aryl)acetal compounds
GB201321734D0 (en) 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561290A (en) * 1975-10-16 1980-02-20 Nyegaard & Co As Pyrimid - 2 - ones
US4044008A (en) * 1976-10-06 1977-08-23 Morton-Norwich Products, Inc. 1-[2-Hydroxy-3-(2-naphthoxy)propyl]-2(1H)pyrimidone hydrochloride
ES498337A0 (es) * 1980-01-07 1982-06-01 Nyegaard & Co As Un procedimiento para la preparacion de 5-halo-pirimidin-2- onas
NZ195992A (en) * 1980-01-10 1983-11-30 Nyegaard & Co As 5-halopyrimidines;their 2-sulphides and s-oxides;pharmaceutical compositions
DK83783A (da) * 1982-02-24 1983-08-25 Nyegaard & Co As Fremgangsmaade til fremstilling af substituerede pyrimidin-2-oner

Also Published As

Publication number Publication date
EP0056319A3 (en) 1982-10-27
DK5382A (da) 1982-07-10
US4596870A (en) 1986-06-24
EP0056319B1 (en) 1986-04-16
ES508593A0 (es) 1983-03-16
ATE19242T1 (de) 1986-05-15
NO160514C (no) 1989-04-26
NO160514B (no) 1989-01-16
NO820049L (no) 1982-07-12
DE3270525D1 (en) 1986-05-22
ES8405771A1 (es) 1984-06-16
CA1180710A (en) 1985-01-08
ES8304945A1 (es) 1983-03-16
JPS57136575A (en) 1982-08-23
EP0056319A2 (en) 1982-07-21
NZ199447A (en) 1985-08-16
ZA82125B (en) 1982-12-29
US4705791A (en) 1987-11-10
AU7929482A (en) 1982-07-15

Similar Documents

Publication Publication Date Title
ES519283A0 (es) Procedimiento para la obtencion de derivados de eter 1-hidroxi-alquil-azoles sustituidos.
ES519282A0 (es) Procedimiento para la obtencion de derivados de 1-hidroxialquilazolilo sustituidos.
ES517865A0 (es) Un procedimiento para la preparacion de pirimidin-2-onas-sustituidas.
ES8301890A1 (es) Procedimiento para la preparacion de nuevas fenilalcohilaminas .
DK55683A (da) Fungicide indanylbenzamider samt fremgangsmaade til fremstilling heraf
ES520774A0 (es) Procedimiento para la preparacion de derivados de tiometilpiridina.
ES520059A0 (es) Un procedimiento para la preparacion de pirimidin-2-onas sustituidas.
DE3561061D1 (en) N-(arylpropyl) azolylureas and fungicides containing them
ES546555A0 (es) Procedimiento para la obtencion de benzodisultamas
ES8600204A1 (es) Procedimiento de preparacion de nuevos deridados de alfa-etibenzol con un grupo amino propanolico sustituido y sus sales de adicion acidas y amonicas cuaternarias.
ES2057455T3 (es) Procedimiento de preparacion de isomeros opticos de los derivados de la 1,4-dihidro-piridina.
ES463647A1 (es) Procedimiento para preparar derivados de azolil-9,10-dihi- droantraceno.
EP0192992A3 (en) Quinoxaline derivatives useful for treatment and prophilaxis of swine dysentery and as animal growth promotants